Unraveling the Molecular Pathways of Insulin‐Producing Cells Derived From Placenta Multipotent Stem Cells via Multi‐Omics Analysis
PROTEOMICS · 2026-07 · 26 (7) · 57-68
DOI: 10.1002/pmic.70120 ↗Kurz gefasst
Fachartikel in der Zeitschrift PROTEOMICS, online erschienen am 01.04.2026. Verfasst von Jie Xu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Louisiana State University Health - Shreveport, Shreveport, USA. Hauptthemen laut MEDLINE: Multipotent Stem Cells, Placenta, Insulin, Insulin-Secreting Cells. Die Arbeit nennt 50 Literaturangaben. Gefördert von: Center for Applied Immunology and Pathological Processes (CAIPP), LSUHS Metabolic and Liver Disease Research Program.
Abstract (Originalsprache)
Stem cell‐derived insulin‐producing cells (Ins‐PCs) hold great promise for diabetes treatment. Placenta‐derived multipotent stem cells (PMSCs) are considered an ideal source of Ins‐PC generation due to their immunomodulatory and differentiation properties. However, the cellular and molecular pathways underlying PMSC differentiation to Ins‐PCs have not been fully elucidated. In this study, PMSCs were isolated from human placenta and successfully differentiated into Ins‐PCs using miRNA‐181a mimics. Differentiated Ins‐PCs produced a significant amount of insulin and upregulation of C‐peptide, insulin, and MAFA expression, compared to undifferentiated control PMSCs. RNA sequencing and LC‐MS/MS were performed to uncover the pathways involved in the Ins‐PC differentiation process. RNA sequencing revealed the transcriptional landscape of PMSC‐derived Ins‐PC differentiation. Pathway analysis identified important pathways involved in the differentiation process, including Notch and Wnt/ß‐catenin, and so forth. Proteomics analysis further affirmed the presence of key insulin pathway‐related proteins involved in the differentiation of PMSCs into Ins‐PCs, including LEPR, STC2, MAP2K2, and so forth. Moreover, integrated transcriptomic and proteomic analyses further highlighted LEPR as a potential key regulator for Ins‐PC differentiation. These findings demonstrated the feasibility of generating Ins‐PCs from PMSCs and identified potential signaling pathways and regulators underlying Ins‐PC differentiation, supporting PMSCs as a promising stem cell source of cell‐based therapy for diabetes treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Louisiana State University Health - Shreveport, Shreveport, USA.
- Department of Pathology, Louisiana State University Health - Shreveport, Shreveport, USA.
ORCID-Profile: Jie Xu, Xinggui Shen, Yang Gu, David F Lewis, Dani Zoorob, Yuping Wang
Förderung
- Center for Applied Immunology and Pathological Processes (CAIPP)
- LSUHS Metabolic and Liver Disease Research Program
Zitieren
APA
Xu, J., Shen, X., Gu, Y., Lewis, D. F., Zoorob, D., & Wang, Y. (2026). Unraveling the Molecular Pathways of Insulin‐Producing Cells Derived From Placenta Multipotent Stem Cells via Multi‐Omics Analysis. PROTEOMICS, 26(7), 57-68. https://doi.org/10.1002/pmic.70120
Vancouver
Xu J, Shen X, Gu Y, Lewis DF, Zoorob D, Wang Y. Unraveling the Molecular Pathways of Insulin‐Producing Cells Derived From Placenta Multipotent Stem Cells via Multi‐Omics Analysis. PROTEOMICS. 2026;26(7):57-68. doi:10.1002/pmic.70120
BibTeX
@article{Xu2026,
author = {Xu, Jie and Shen, Xinggui and Gu, Yang and Lewis, David F and Zoorob, Dani and Wang, Yuping},
title = {Unraveling the Molecular Pathways of Insulin‐Producing Cells Derived From Placenta Multipotent Stem Cells via Multi‐Omics Analysis},
journal = {PROTEOMICS},
year = {2026},
volume = {26},
number = {7},
pages = {57--68},
doi = {10.1002/pmic.70120}
}
EUVIMED